+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rare Disease Genetic Testing Market by Technology (Microarray, Next Generation Sequencing, Polymerase Chain Reaction), Test Type (Exome Sequencing, Genome Sequencing, Panel Test), End User, Application, Disease Indication - Global Forecast 2025-2030- Product Image
Rare Disease Genetic Testing Market by Technology (Microarray, Next Generation Sequencing, Polymerase Chain Reaction), Test Type (Exome Sequencing, Genome Sequencing, Panel Test), End User, Application, Disease Indication - Global Forecast 2025-2030- Product Image
Sale

Rare Disease Genetic Testing Market by Technology (Microarray, Next Generation Sequencing, Polymerase Chain Reaction), Test Type (Exome Sequencing, Genome Sequencing, Panel Test), End User, Application, Disease Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533238
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The rare disease genetic testing market is entering a phase of accelerated transformation, shaped by precision diagnostics, innovative technologies, and regulatory shifts. Strategic collaboration across industry sectors is redefining patient care and unlocking new pathways for growth and value generation.

Market Snapshot: Rare Disease Genetic Testing Market Outlook

The Rare Disease Genetic Testing Market grew from USD 1.54 billion in 2024 to USD 1.79 billion in 2025. It is expected to continue growing at a CAGR of 16.28%, reaching USD 3.80 billion by 2030. This expansion reflects the integration of advanced sequencing technologies, increasing adoption of personalized medicine, and greater stakeholder collaboration. As rare disease diagnostics achieve mainstream clinical adoption, the market is positioned for ongoing evolution, shaped by new reimbursement models, data-driven regulatory approaches, and active involvement from technology providers, laboratories, and advocacy organizations.

Scope & Segmentation

This report delivers in-depth coverage of the rare disease genetic testing market, analyzing core segments and geographic expansion opportunities.

  • Technology Platforms: Microarray, next generation sequencing (including sequencing by ligation and sequencing by synthesis), and polymerase chain reaction (digital PCR, quantitative PCR).
  • Test Types: Exome sequencing (clinical, research), genome sequencing (targeted, whole), panel tests (cancer, cardiovascular, neurological), and single gene tests.
  • End Users: Diagnostic laboratories, hospitals (private and public), research institutions, specialty clinics.
  • Application Domains: Carrier screening, diagnostics, newborn screening, prenatal screening (invasive, non-invasive), research applications.
  • Disease Indications: Hematological disorders, metabolic disorders (enzyme deficiencies, mitochondrial disorders), neuromuscular disorders, oncology.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and additional major markets), and Asia-Pacific (including China, India, Japan, Australia, and others).
  • Company Profiles: Analysis of Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, QIAGEN, PerkinElmer, Bio-Rad Laboratories, Myriad Genetics, Invitae, Natera, Eurofins Scientific.

Key Takeaways for Senior Decision-Makers

  • Emerging diagnostic platforms are driving workflow enhancements and enabling the detection of rare genetic variants once missed by conventional assays.
  • Collaborative partnerships among technology providers, laboratories, and patient advocacy groups are shaping value-based healthcare solutions and supporting clinical validation.
  • Increased focus on patient access is encouraging adoption of remote testing, telehealth, and data-driven care models, especially in under-resourced regions.
  • Regional diversification strategies allow companies to address varied reimbursement pathways and lab infrastructure, fostering market entry in both developed and emerging economies.
  • Operational adaptation and automation are becoming critical as cost pressures mount, with laboratories emphasizing efficiency to maintain service quality despite rising input expenses.

Tariff Impact: Market Implications of US Regulatory Changes

Upcoming US tariffs on imported reagents and sequencing equipment are prompting supply chain reevaluation. Laboratories are exploring more localized procurement strategies, which shifts traditional sourcing patterns and spurs investment in domestic manufacturing partnerships. Organizations are countering cost inflation with automation, long-term contracts, and technology adaption to protect margins and sustain service continuity. Active industry advocacy is ongoing to address anticipated disruptions and adapt to evolving policy scenarios.

Methodology & Data Sources

This research employs a robust, multimethod approach, combining structured executive interviews with a comprehensive review of scientific literature, regulatory documents, trade records, and company filings. Peer review by domain experts ensures accuracy and consistency of qualitative and quantitative insights.

Why This Report Matters

  • Provides actionable intelligence supporting technology investment decisions, supplier partnerships, and new market entry strategies within the rare disease genetic testing sector.
  • Enables strategic alignment with the latest market trends, regulatory frameworks, and industry consolidation activities.
  • Guides product portfolio and network expansion through detailed segmentation analysis and competitive profiling of industry leaders.

Conclusion

The rare disease genetic testing market is entering a critical phase of innovation, regulatory change, and global expansion. Decision-makers equipped with up-to-date segment insights and supply chain strategies will be well positioned to lead successful growth initiatives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of single-cell sequencing in early rare disease genetic diagnostics to uncover mosaicism and complex mutations
5.2. Expansion of newborn screening panels using CRISPR-based point-of-care genetic testing for early rare disease detection
5.3. Growing collaborations between academic research centers and biopharma for gene therapy development in ultra-rare disorders
5.4. Adoption of AI-driven variant interpretation platforms to reduce diagnostic odyssey in complex rare disease cases
5.5. Increasing patient-led genetic data sharing platforms to accelerate novel gene discovery and personalized diagnostics
5.6. Rising demand for pharmacogenomic rare disease testing to tailor orphan drug selection and optimize treatment outcomes
5.7. Regulatory advances enabling wider access to exome and genome sequencing as first-tier diagnostic tests in pediatric rare diseases
5.8. Implementation of multiplex digital PCR assays for cost-effective population screening of founder mutations in targeted communities
5.9. Expansion of remote genetic counseling services leveraging telehealth to improve patient access in underserved rare disease populations
5.10. Development of long-read sequencing technologies to detect structural variants implicated in challenging rare neurological disorders
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rare Disease Genetic Testing Market, by Technology
8.1. Introduction
8.2. Microarray
8.3. Next Generation Sequencing
8.3.1. Sequencing By Ligation
8.3.2. Sequencing By Synthesis
8.4. Polymerase Chain Reaction
8.4.1. Digital PCR
8.4.2. Quantitative PCR
9. Rare Disease Genetic Testing Market, by Test Type
9.1. Introduction
9.2. Exome Sequencing
9.2.1. Clinical Exome
9.2.2. Research Exome
9.3. Genome Sequencing
9.3.1. Targeted Genome
9.3.2. Whole Genome
9.4. Panel Test
9.4.1. Cancer Panels
9.4.2. Cardiovascular Panels
9.4.3. Neurological Panels
9.5. Single Gene Test
10. Rare Disease Genetic Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Research Institutions
10.5. Specialty Clinics
11. Rare Disease Genetic Testing Market, by Application
11.1. Introduction
11.2. Carrier Screening
11.3. Diagnostics
11.4. Newborn Screening
11.5. Prenatal Screening
11.5.1. Invasive
11.5.2. Non Invasive
11.6. Research Applications
12. Rare Disease Genetic Testing Market, by Disease Indication
12.1. Introduction
12.2. Hematological Disorders
12.3. Metabolic Disorders
12.3.1. Enzyme Deficiencies
12.3.2. Mitochondrial Disorders
12.4. Neuromuscular Disorders
12.5. Oncology
13. Americas Rare Disease Genetic Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Rare Disease Genetic Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Rare Disease Genetic Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Illumina, Inc.
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. F. Hoffmann-La Roche AG
16.3.4. QIAGEN N.V.
16.3.5. PerkinElmer, Inc.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Myriad Genetics, Inc.
16.3.8. Invitae Corporation
16.3.9. Natera, Inc.
16.3.10. Eurofins Scientific SE
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RARE DISEASE GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RARE DISEASE GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RARE DISEASE GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RARE DISEASE GENETIC TESTING MARKET: RESEARCHAI
FIGURE 26. RARE DISEASE GENETIC TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. RARE DISEASE GENETIC TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. RARE DISEASE GENETIC TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RARE DISEASE GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CLINICAL EXOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CLINICAL EXOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH EXOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH EXOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TARGETED GENOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TARGETED GENOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY WHOLE GENOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY WHOLE GENOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CANCER PANELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CANCER PANELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR PANELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR PANELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEUROLOGICAL PANELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEUROLOGICAL PANELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SINGLE GENE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SINGLE GENE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NON INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY ENZYME DEFICIENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY ENZYME DEFICIENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 165. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 168. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 169. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 170. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 171. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 174. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 175. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 176. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 177. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2024 (USD MILLION)
TABLE 178. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2025-2030 (USD MILLION)
TABLE 179. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 186. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 187. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 190. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 194. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 195. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 196. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 197. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 200. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 201. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 202. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 203. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2024 (USD MILLION)
TABLE 204. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2025-2030 (USD MILLION)
TABLE 205. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 212. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 213. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 214. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 215. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM RARE DISEASE GENETIC T

Samples

Loading
LOADING...

Companies Mentioned

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Myriad Genetics, Inc.
  • Invitae Corporation
  • Natera, Inc.
  • Eurofins Scientific SE

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.8 Billion
Compound Annual Growth Rate16.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report By Disease (Neurological Disorders), By Technology (Next Generation Sequencing, Array Technology, PCR-based Testing), By Specialty, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report By Disease (Neurological Disorders), By Technology (Next Generation Sequencing, Array Technology, PCR-based Testing), By Specialty, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Predictive Genetics Market by Technology (Microarray, Next Generation Sequencing, Polymerase Chain Reaction), Test Type (Cancer Screening, Carrier Screening, Pharmacogenomics), Application, End User, Product Type - Global Forecast 2025-2030 - Product Image

Predictive Genetics Market by Technology (Microarray, Next Generation Sequencing, Polymerase Chain Reaction), Test Type (Cancer Screening, Carrier Screening, Pharmacogenomics), Application, End User, Product Type - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Rare Disease Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Rare Disease Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Whole Genome and Exome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Whole Genome and Exome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Global Whole Genome and Exome Sequencing Market: Focus on Product, Workflow, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Global Whole Genome and Exome Sequencing Market: Focus on Product, Workflow, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 106 Pages
  • Global
From

About the Rare Disease Genetic Testing Market

The Rare Disease Genetic Testing market is a subset of the larger Genomics market. It focuses on the diagnosis and treatment of rare genetic diseases, which are caused by mutations in a single gene. These tests are used to identify the genetic cause of a disease, as well as to predict the risk of developing a disease in the future. They can also be used to identify the best treatment options for a particular patient. The Rare Disease Genetic Testing market is growing rapidly, driven by advances in technology and the increasing availability of genetic testing services. This has enabled more accurate diagnosis and treatment of rare diseases, as well as the development of new treatments. Companies in the Rare Disease Genetic Testing market include Ambry Genetics, Invitae, Counsyl, and GeneDx. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.